SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-080169
Filing Date
2021-06-11
Accepted
2021-06-11 16:29:13
Documents
12
Period of Report
2021-06-09
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2119507d1_8k.htm   iXBRL 8-K 31546
  Complete submission text file 0001104659-21-080169.txt   209650

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vrna-20210609.xsd EX-101.SCH 3199
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrna-20210609_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrna-20210609_pre.xml EX-101.PRE 22719
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2119507d1_8k_htm.xml XML 3702
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38067 | Film No.: 211011658
SIC: 2834 Pharmaceutical Preparations